Let’s start up with the current stock price of 180 Life Sciences Corp. (ATNF), which is $2.58 to be very precise. The Stock rose vividly during the last session to $2.63 after opening rate of $2.61 while the lowest price it went was recorded $2.51 before closing at $2.53.
Recently in News on January 5, 2021, 180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference. 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that the Company will present at the H.C. Wainwright Bioconnect 2021 Conference. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
180 Life Sciences Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.74 on 01/06/21, with the lowest value was $2.41 for the same time period, recorded on 01/04/21.
180 Life Sciences Corp. (ATNF) full year performance was -74.51%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, 180 Life Sciences Corp. shares are logging -77.57% during the 52-week period from high price, and 35.79% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.90 and $11.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 390447 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the 180 Life Sciences Corp. (ATNF) recorded performance in the market was -5.49%, having the revenues showcasing -76.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 45.36M, as it employees total of 2 workers.
Specialists analysis on 180 Life Sciences Corp. (ATNF)
During the last month, 0 analysts gave the 180 Life Sciences Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.29, with a change in the price was noted -8.42. In a similar fashion, 180 Life Sciences Corp. posted a movement of -76.55% for the period of last 100 days, recording 475,739 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATNF is recording 0.37 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: 180 Life Sciences Corp. (ATNF)
Raw Stochastic average of 180 Life Sciences Corp. in the period of last 50 days is set at 7.36%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 29.20%. In the last 20 days, the company’s Stochastic %K was 30.66% and its Stochastic %D was recorded 31.14%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -5.49%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -75.93%, alongside a downfall of -74.51% for the period of the last 12 months. The shares increased approximately by -3.01% in the 7-day charts and went down by 1.57% in the period of the last 30 days. Common stock shares were lifted by -76.35% during last recorded quarter.